申请人:The General Hospital Corporation
公开号:US20200277264A1
公开(公告)日:2020-09-03
The present application provides compounds useful for treating disorders associated with abnormal steroidogenesis. Methods of treating disorders associated with abnormal steroidogenesis, methods of inhibiting 11β-hydroxylase activity, and pharmaceutical compositions comprising the compounds are also provided.